-transparent.png){kind=logo}
To construct a mouse/human chimeric antibody, we cloned the genomic DNAs for Ig from a murine hybridoma that produces PL7-6 monoclonal antibody specific to human P-selectin and expressed them in SP2/0 myelomas using a series of pSV2 vectors. Transfected cells that produce the mouse/human chimeric anti-human P-selectin antibody were geneticin-selected and screened by an immunoassay using immobilized antigen. The chimeric antibody, cPL-2R1, expressed by the resultant clone has the murine Ig variable region and the human Ig constant region. The native antibody PL7-6 and the chimeric antibody cPL-2R1 react equally with purified P-selectin and thrombin-stimulated platelets. Competitive inhibition tests demonstrated that the native antibody PL7-6 and the chimeric antibody cPL-2R1 had identical affinity for purified human P-selectin. Thus, although human IgG1 constant region was substituted for the murine counterpart in this chimeric antibody, its specificity and binding affinity for P-selectin was not altered. This chimeric antibody may prove useful when employed in combination with imaging reagents or therapeutic drugs for targeting activated platelets or endothelium in patients with thrombosis or intravascular inflammation.
T Kurome, and
M Katayama, and
K Murakami, and
K Hashino, and
K Kamihagi, and
M Yasumoto, and
I Kato
August 1992,
Journal of immunological methods,
T Kurome, and
M Katayama, and
K Murakami, and
K Hashino, and
K Kamihagi, and
M Yasumoto, and
I Kato
April 1997,
Thrombosis and haemostasis,
T Kurome, and
M Katayama, and
K Murakami, and
K Hashino, and
K Kamihagi, and
M Yasumoto, and
I Kato
November 1993,
Transplantation,
T Kurome, and
M Katayama, and
K Murakami, and
K Hashino, and
K Kamihagi, and
M Yasumoto, and
I Kato
April 1992,
The Journal of experimental medicine,
T Kurome, and
M Katayama, and
K Murakami, and
K Hashino, and
K Kamihagi, and
M Yasumoto, and
I Kato
June 2000,
Transplantation,
T Kurome, and
M Katayama, and
K Murakami, and
K Hashino, and
K Kamihagi, and
M Yasumoto, and
I Kato
October 1992,
The Journal of clinical investigation,
T Kurome, and
M Katayama, and
K Murakami, and
K Hashino, and
K Kamihagi, and
M Yasumoto, and
I Kato
February 1991,
Hybridoma,
T Kurome, and
M Katayama, and
K Murakami, and
K Hashino, and
K Kamihagi, and
M Yasumoto, and
I Kato
July 1992,
Blood,
T Kurome, and
M Katayama, and
K Murakami, and
K Hashino, and
K Kamihagi, and
M Yasumoto, and
I Kato
March 1992,
Biochemical and biophysical research communications,
T Kurome, and
M Katayama, and
K Murakami, and
K Hashino, and
K Kamihagi, and
M Yasumoto, and
I Kato
February 1987,
Cancer research,
